Literature DB >> 33569668

Update on Post-Streptococcal Reactive Arthritis: Narrative Review of a Forgotten Disease.

Sakir Ahmed1, Prasanta Padhan1, Ramnath Misra1, Debashish Danda2.   

Abstract

PURPOSE OF THE REVIEW: This topical review attempts to build the concepts of PSRA as an independent entity and discuss prevalent diagnostic criteria. It utilizes a search strategy to collate all clinical features of PSRA reported from across the world and also discusses laboratory and treatment options in brief. RECENT
FINDINGS: There are several immune-mediated diseases described after acute streptococcal infections. Post-streptococcal reactive arthritis (PSRA) is a sterile, self-limiting arthritis that occur as an immune sequelae to streptococcal infection. Though PSRA resembles the arthritis of acute rheumatic fever superficially, it is a separate entity in its own right. It is different from classical reactive arthritis too. It was being recognized worldwide and more frequently in the recent past, possibly due to heightened awareness amongst clinicians. However, research on this enigmatic immune phenomenon is limited. Most acceptable hypotheses suggest molecular mimicry sensitizing the immune system towards synovial peptides such as keratin, vimentin and laminin, leading to arthritis in a genetically predisposed individual. There is still much to be learnt from this unique disease about the vagaries of the immune system.

Entities:  

Keywords:  Group B Streptococcus; Molecular mimicry; Post-infection arthritis; Streptococcal

Year:  2021        PMID: 33569668     DOI: 10.1007/s11926-021-00982-3

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  41 in total

1.  The challenge of treating orphan disease.

Authors:  Carlos Dias; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

2.  Group A Streptococcal Virulence: New Lessons.

Authors:  Stanford T Shulman; James B Dale
Journal:  J Pediatric Infect Dis Soc       Date:  2019-05-11       Impact factor: 3.164

Review 3.  Clinical trials for post-streptococcal reactive arthritis.

Authors:  T J Lehman; B S Edelheit
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

4.  Extrarenal Immune-Mediated Disorders Linked with Acute Poststreptococcal Glomerulonephritis: a Systematic Review.

Authors:  Elena A Bertola; Giacomo D Simonetti; Rosaria Del Giorno; Olivier Giannini; Emilio F Fossali; Martina Meoli; Mario G Bianchetti; Benedetta Terziroli Beretta-Piccoli; Gregorio P Milani
Journal:  Clin Rev Allergy Immunol       Date:  2019-10       Impact factor: 8.667

Review 5.  Acute rheumatic fever and poststreptococcal reactive arthritis reconsidered.

Authors:  Annette H M van der Helm-van Mil
Journal:  Curr Opin Rheumatol       Date:  2010-07       Impact factor: 5.006

Review 6.  Beta haemolytic streptococci and reactive arthritis in adults.

Authors:  C Deighton
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

Review 7.  Poststreptococcal reactive arthritis.

Authors:  Stanford T Shulman; Elia M Ayoub
Journal:  Curr Opin Rheumatol       Date:  2002-09       Impact factor: 5.006

8.  Post-streptococcal reactive arthritis in children: a distinct entity from acute rheumatic fever.

Authors:  Yosef Uziel; Liat Perl; Judith Barash; Philip J Hashkes
Journal:  Pediatr Rheumatol Online J       Date:  2011-10-20       Impact factor: 3.054

Review 9.  Reactive arthritis: update 2018.

Authors:  A García-Kutzbach; J Chacón-Súchite; H García-Ferrer; I Iraheta
Journal:  Clin Rheumatol       Date:  2018-02-17       Impact factor: 3.650

10.  Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.

Authors:  Ruth Gilbert; Michaela Brown; Rita Faria; Caroline Fraser; Chloe Donohue; Naomi Rainford; Alessandro Grosso; Ajay K Sinha; Jon Dorling; Jim Gray; Berit Muller-Pebody; Katie Harron; Tracy Moitt; William McGuire; Laura Bojke; Carrol Gamble; Sam J Oddie
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.106

View more
  3 in total

Review 1.  Reactive arthritis before and after the onset of the COVID-19 pandemic.

Authors:  Dana Bekaryssova; Marlen Yessirkepov; Olena Zimba; Armen Yuri Gasparyan; Sakir Ahmed
Journal:  Clin Rheumatol       Date:  2022-03-05       Impact factor: 3.650

2.  Revisiting reactive arthritis during the COVID-19 pandemic.

Authors:  Dana Bekaryssova; Marlen Yessirkepov; Olena Zimba; Armen Yuri Gasparyan; Sakir Ahmed
Journal:  Clin Rheumatol       Date:  2022-07-07       Impact factor: 3.650

3.  HLA-B27 negative reactive arthritis versus HLA-B27 positive reactive arthritis: A retrospective study.

Authors:  Yimei Ding; Luan Xue
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.